iSpecimen 

$0.14
26
-$0.01-7.83% Today

Statistics

Day High
0.15
Day Low
0.14
52W High
3.18
52W Low
0.14
Volume
1,232,084
Avg. Volume
7,714,586
Mkt Cap
1.37M
P/E Ratio
-
Dividend Yield
-
Dividend
-

Earnings

1AprExpected
Q1 2024
Q2 2024
Q3 2024
Q1 2025
Q2 2025
Q3 2025
Q1 2026
-5.6
-3.82
-2.05
-0.27
Expected EPS
N/A
Actual EPS
-0.74

Financials

-134.52%Profit Margin
Unprofitable
2019
2020
2021
2022
2023
2024
18.58MRevenue
-25MNet Income

People Also Follow

This list is based on the watchlists of people on Stock Events who follow ISPC. It's not an investment recommendation.

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Thermo Fisher Scientific
TMO
Mkt Cap214.25B
Thermo Fisher Scientific offers a broad range of services and products for scientific research and healthcare, including specimen collection and processing, directly competing with iSpecimen's core services.
Bio-Rad Laboratories
BIO
Mkt Cap8.54B
Bio-Rad Laboratories provides a variety of products and services for life science research and clinical diagnostics, competing in the specimen collection and analysis market.
Mettler-Toledo International
MTD
Mkt Cap29.17B
Mettler-Toledo International is involved in precision instruments and services for professional use, including laboratory equipment that can be used in specimen analysis, overlapping with iSpecimen's market.
Agilent Technologies
A
Mkt Cap41.49B
Agilent Technologies provides instruments, services, consumables, applications, and expertise for laboratory workflow, including specimen analysis, making it a competitor.
Quest Diagnostics
DGX
Mkt Cap19.57B
Quest Diagnostics offers diagnostic testing services, including specimen collection and processing, directly competing with iSpecimen's services.
Labcorp
LH
Mkt Cap21.08B
Laboratory Corporation of America Holdings operates as a life sciences company and a direct competitor in clinical laboratory and end-to-end drug development services.
Bruker
BRKR
Mkt Cap5.91B
Bruker Corporation designs and manufactures scientific instruments, and analytical and diagnostic solutions that can be used in specimen analysis, competing with iSpecimen.
Waters
WAT
Mkt Cap20.81B
Waters Corporation produces analytical standards and reagents, chromatography columns, and sample preparation products, which are used in specimen analysis, making it a competitor.
Guardant Health
GH
Mkt Cap11.72B
Guardant Health focuses on liquid biopsies and cancer diagnostics, competing in the niche of specimen analysis for healthcare research and diagnostics, similar to iSpecimen's market focus.

About

iSpecimen Inc. provides technology that connects life science researchers who need human biofluids, tissues, and living cells for their research with biospecimens available in healthcare provider organizations worldwide. Its cloud-based technology enables scientists to search for specimens and patients across a network of hospitals, labs, biobanks, blood centers, and other healthcare organizations. The company develops and operates iSpecimen Marketplace, a proprietary online marketplace platform that connects medical researchers who need access to subjects, samples, and data with hospitals, laboratories, and other organizations who have access to them. It serves biopharmaceutical companies, in vitro diagnostic companies, and government/academic institutions. The company was incorporated in 2009 and is headquartered in Lexington, Massachusetts.
Show more...
CEO
Mr. Robert Bradley Lim
Employees
24
Country
US
ISIN
US45032V2079

Listings

0 Comments

Share your thoughts

FAQ

What is iSpecimen stock price today?
The current price of ISPC is $0.14 USD — it has decreased by -7.83% in the past 24 hours. Watch iSpecimen stock price performance more closely on the chart.
What is iSpecimen stock ticker?
Depending on the exchange, the stock ticker may vary. For instance, on exchange iSpecimen stocks are traded under the ticker ISPC.
Is iSpecimen stock price growing?
ISPC stock has fallen by -10.82% compared to the previous week, the month change is a -45.83% fall, over the last year iSpecimen has showed a -88.91% decrease.
What is iSpecimen market cap?
Today iSpecimen has the market capitalization of 1.37M
What were iSpecimen earnings last quarter?
ISPC earnings for the last quarter are -0.74 USD per share, whereas the estimation was N/A USD resulting in a N/A surprise. The estimated earnings for the next quarter are N/A USD per share.
What is iSpecimen revenue for the last year?
iSpecimen revenue for the last year amounts to 18.58M USD.
What is iSpecimen net income for the last year?
ISPC net income for the last year is -25M USD.
How many employees does iSpecimen have?
As of April 02, 2026, the company has 24 employees.
In which sector is iSpecimen located?
iSpecimen operates in the Health Care sector.
When did iSpecimen complete a stock split?
The last stock split for iSpecimen was on September 16, 2024 with a ratio of 1:20.
Where is iSpecimen headquartered?
iSpecimen is headquartered in Woburn, US.